150 related articles for article (PubMed ID: 3093608)
1. Activated macrophages as effector cells of protective immunity to schistosomiasis.
James SL
Immunol Res; 1986; 5(2):139-48. PubMed ID: 3093608
[No Abstract] [Full Text] [Related]
2. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
3. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
James SL
J Immunol; 1986 May; 136(10):3872-7. PubMed ID: 3084646
[TBL] [Abstract][Full Text] [Related]
4. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. VI. Antigen recognition by non-responder mouse strains.
James SL; Salzman C; Pearce EJ
Parasite Immunol; 1988 Jan; 10(1):71-83. PubMed ID: 3127798
[TBL] [Abstract][Full Text] [Related]
5. Macrophages as effector cells of protective immunity in murine schistosomiasis. IV. Coincident induction of macrophage activation for extracellular killing of schistosomula and tumor cells.
James SL; Leonard EJ; Meltzer MS
Cell Immunol; 1982 Nov; 74(1):86-96. PubMed ID: 7159937
[No Abstract] [Full Text] [Related]
6. The production of macrophage aggregation factor (MAF) by in vitro cultured Schistosoma mansoni egg granulomas isolated from experimentally infected mice.
Giron ME; Rodriguez-Acosta FA
Arch Roum Pathol Exp Microbiol; 1987; 46(1):83-7. PubMed ID: 3124796
[No Abstract] [Full Text] [Related]
7. Genetic association of defects in macrophage larvicidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain mice.
James SL; Correa-Oliveira R; Sher A; Medvitz LA; McCall RD
Infect Immun; 1987 Aug; 55(8):1884-9. PubMed ID: 3112016
[TBL] [Abstract][Full Text] [Related]
8. Induction of cell-mediated immunity as a strategy for vaccination against Schistosoma mansoni.
James SL; Pearce EJ; Lanar D; Sher A
Acta Trop Suppl; 1987 Jun; 12():50-4. PubMed ID: 3115075
[No Abstract] [Full Text] [Related]
9. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
James SL; Pearce EJ
J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
[TBL] [Abstract][Full Text] [Related]
10. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
James SL; Deblois LA; Al-Zamel F; Glaven J; Langhorne J
J Immunol; 1986 Dec; 137(12):3959-67. PubMed ID: 3097138
[TBL] [Abstract][Full Text] [Related]
11. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
James SL; Correa-Oliveira R; Leonard EJ
J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. IV. Fractionation and antigenic properties of a soluble adult worm immunoprophylactic activity.
Sher A; Pearce E; Hieny S; James S
J Immunol; 1986 May; 136(10):3878-83. PubMed ID: 3084647
[TBL] [Abstract][Full Text] [Related]
13. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
14. Genetic control of vaccine-induced immunity against a parasitic helminth, Schistosoma mansoni.
Sher A; James S
Bioessays; 1988 Nov; 9(5):163-6. PubMed ID: 3149197
[No Abstract] [Full Text] [Related]
15. Comparison of immune responses between high and low responder strains of mice in the concomitant immunity and vaccine models of resistance to Schistosoma mansoni.
James SL; Cheever AW
Parasitology; 1985 Oct; 91 ( Pt 2)():301-15. PubMed ID: 3934632
[TBL] [Abstract][Full Text] [Related]
16. Prospects for a nonliving vaccine against schistosomiasis based on cell-mediated immune resistance mechanisms.
James SL; Pearce EJ; Sher A
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():121-3. PubMed ID: 3151085
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation as an immune correlate to protective immunity against schistosomiasis in mice immunized with an irradiated, cryopreserved live vaccine.
Lewis FA; Winestock J; James SL
Infect Immun; 1987 Jun; 55(6):1339-45. PubMed ID: 3106218
[TBL] [Abstract][Full Text] [Related]
18. Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stage.
Sher A; James SL; Simpson AJ; Lazdins JK; Meltzer MS
J Immunol; 1982 Apr; 128(4):1876-9. PubMed ID: 7061853
[TBL] [Abstract][Full Text] [Related]
19. In vivo activation of macrophages by T cell-derived lymphokines: killing of tumor cells and schistosomula of Schistosoma mansoni.
Kubelka CF; Ruppel A; Gemsa D; Krammer PH
Immunobiology; 1986 Jul; 171(4-5):311-9. PubMed ID: 3091486
[TBL] [Abstract][Full Text] [Related]
20. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
James SL; Sher A; Lazdins JK; Meltzer MS
J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
